These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 19485802)

  • 41. Significance of alpha-fetoprotein and des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma undergoing hepatectomy.
    Yamamoto K; Imamura H; Matsuyama Y; Hasegawa K; Beck Y; Sugawara Y; Makuuchi M; Kokudo N
    Ann Surg Oncol; 2009 Oct; 16(10):2795-804. PubMed ID: 19669841
    [TBL] [Abstract][Full Text] [Related]  

  • 42. KL-6 mucin in metastatic liver cancer tissues from primary colorectal carcinoma.
    Zhang K; Tang W; Qu X; Guo Q; Inagaki Y; Seyama Y; Abe H; Gai R; Kokudo N; Sugawara Y; Nakata M; Makuuchi M
    Hepatogastroenterology; 2009; 56(93):960-3. PubMed ID: 19760920
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Differentiating early and late recurrences after resection of HCC in cirrhotic patients: implications on surveillance, prevention, and treatment strategies.
    Poon RT
    Ann Surg Oncol; 2009 Apr; 16(4):792-4. PubMed ID: 19190964
    [No Abstract]   [Full Text] [Related]  

  • 44. Hepatocellular carcinoma and liver transplantation: entering the area after the Milan and University of California at San Francisco criteria?
    Weber M; Clavien PA
    Liver Transpl; 2008 Jul; 14(7):911-4. PubMed ID: 18581506
    [No Abstract]   [Full Text] [Related]  

  • 45. Golgi protein 73 as a biomarker of hepatocellular cancer: development of a quantitative serum assay and expression studies in hepatic and extrahepatic malignancies.
    Fimmel CJ; Wright L
    Hepatology; 2009 May; 49(5):1421-3. PubMed ID: 19402061
    [No Abstract]   [Full Text] [Related]  

  • 46. Fascin expression in progression and prognosis of hepatocellular carcinoma.
    Iguchi T; Aishima S; Umeda K; Sanefuji K; Fujita N; Sugimachi K; Gion T; Taketomi A; Maehara Y; Tsuneyoshi M
    J Surg Oncol; 2009 Dec; 100(7):575-9. PubMed ID: 19697358
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Viable strategies to facilitate liver transplantation for human immunodeficiency virus coinfection.
    Stock PG; Fung J
    Liver Transpl; 2009 Sep; 15(9):1003-6. PubMed ID: 19718639
    [No Abstract]   [Full Text] [Related]  

  • 48. Natural killer cells play divergent roles in shaping the outcome of hepatitis C virus recurrence following liver transplantation.
    Golden-Mason L
    Liver Transpl; 2009 Apr; 15(4):357-9. PubMed ID: 19326413
    [No Abstract]   [Full Text] [Related]  

  • 49. Human leukocyte antigen-G protein expression is an unfavorable prognostic predictor of hepatocellular carcinoma following curative resection.
    Cai MY; Xu YF; Qiu SJ; Ju MJ; Gao Q; Li YW; Zhang BH; Zhou J; Fan J
    Clin Cancer Res; 2009 Jul; 15(14):4686-93. PubMed ID: 19584149
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Glypican-3: a novel diagnostic marker for hepatocellular carcinoma and more.
    Kandil DH; Cooper K
    Adv Anat Pathol; 2009 Mar; 16(2):125-9. PubMed ID: 19550373
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Liberal selection criteria for liver transplantation for hepatocellular carcinoma.
    Muscari F; Foppa B; Kamar N; Peron JM; Selves J; Suc B
    Br J Surg; 2009 Jul; 96(7):785-91. PubMed ID: 19526621
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The epithelial-mesenchymal transition: fact or fiction in cancer?
    Giannelli G
    Hepatology; 2009 Nov; 50(5):1344-6. PubMed ID: 19877297
    [No Abstract]   [Full Text] [Related]  

  • 53. Predicting recurrence after liver transplantation in patients with hepatocellular carcinoma exceeding the up-to-seven criteria.
    D'Amico F; Schwartz M; Vitale A; Tabrizian P; Roayaie S; Thung S; Guido M; del Rio Martin J; Schiano T; Cillo U
    Liver Transpl; 2009 Oct; 15(10):1278-87. PubMed ID: 19790142
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [What are the indications of liver transplantion in hepatic cancer patients?].
    Fan J; Xu Y; Zhou J
    Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(24):1662-4. PubMed ID: 16251064
    [No Abstract]   [Full Text] [Related]  

  • 55. The influence of intraoperative homologous blood transfusion on prognosis after liver transplantation for hepatocellular carcinoma.
    Kaido T; Takada Y; Egawa H; Uemoto S
    Hepatogastroenterology; 2009; 56(91-92):808-12. PubMed ID: 19621707
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Is absolute lymphocyte count a good prognostic predictor in recurrence of hepatocellular carcinoma after liver transplantation?
    Li C; Wen TF; Yan LN
    Transplantation; 2014 Mar; 97(6):e33. PubMed ID: 24637870
    [No Abstract]   [Full Text] [Related]  

  • 57. Hepatoma-related gamma-glutamyl transferase in laboratory or clinical diagnosis of hepatocellular carcinoma.
    Yao DF; Dong ZZ
    Hepatobiliary Pancreat Dis Int; 2007 Feb; 6(1):9-11. PubMed ID: 17287158
    [No Abstract]   [Full Text] [Related]  

  • 58. Surgical resection of resectable thoracic metastatic hepatocellular carcinoma after liver transplantation.
    Zhang C; Rao J; Tu Z; Ni Y
    J Thorac Cardiovasc Surg; 2009 Jul; 138(1):240-1. PubMed ID: 19577090
    [No Abstract]   [Full Text] [Related]  

  • 59. Liver transplantation for hepatocellular carcinoma.
    Venook AP
    Hepatology; 1993 Jul; 18(1):218-9. PubMed ID: 8392028
    [No Abstract]   [Full Text] [Related]  

  • 60. Recurrence of hepatocellular carcinoma after liver retransplantation.
    Klompmaker IJ; de Bruijn KM; Gouw AH; Bams JI; Slooff MJ
    Br Med J (Clin Res Ed); 1988 May; 296(6634):1445. PubMed ID: 2837306
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.